dendritic cells pulsed with muc-1/wt-1 peptides
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 9, 2017 (NCT03114631)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dendritic cells pulsed with muc-1/wt-1 peptides
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03114631 | Phase 1/Phase 2 (Phase 2) | Jan 9, 2017 | Belarusian State Medical University, The Republican Center for Research and Practice in Otolaryngology, Belarus, The Republican Research and Practical Center for Epidemiology and Microbiology |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Belarusian State Medical University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| The Republican Center for Research and Practice in Otolaryngology, Belarus | Government | 1 | 0 | 1 | 2017 |
| The Republican Research and Practical Center for Epidemiology and Microbiology | Academic/Hospital | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1